Search Results - "Boussioutas, A"

Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic by Lao-Sirieix, P, Boussioutas, A, Kadri, S R, O'Donovan, M, Debiram, I, Das, M, Harihar, L, Fitzgerald, R C

“…Barrett's oesophagus predisposes to oesophageal adenocarcinoma but the majority of patients are undiagnosed. A novel non-endoscopic cytological screening…”
Get more information

Defective macrophage handling of Escherichia coli in Crohn's disease by Elliott, TR, Hudspith, BN, Rayment, NB, Prescott, NJ, Petrovska, L, Hermon-Taylor, J, Brostoff, J, Boussioutas, A, Mathew, CG, Sanderson, JD

“…Background and Aim  Escherichia coli can be isolated from lamina propria macrophages in Crohn's disease (CD), and their intramacrophage persistence may provide…”
Get full text

Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression by Jackson, CB, Judd, LM, Menheniott, TR, Kronborg, I, Dow, C, Yeomans, ND, Boussioutas, A, Robb, L, Giraud, AS

“…H. pylori infection accounts for most cases of gastric cancer, but the initiating events remain unclear. The principal H. pylori pathogenicity-associated CagA…”
Get full text

P-236Screening practices of Australians at population and familial risk following the partial roll-out of the National Bowel Cancer Screening Program, 2009-2012 by Flander, L, Jenkins, M, Win Aung, K, Boussioutas, A, Hopper, J, Giles, G, Winship, I, Macrae, F, Ait Ouakrim, D

Get full text

2384 MMR loss, infiammatory score and prognosis in gastric cancer by Pattison, S, Di Costanzo, N, Mitchell, C, Murray, W, Leong, T, Busuttil, R, Boussioutas, A

Get full text

Preoperative Diagnosis of Lynch Syndrome With DNA Mismatch Repair Immunohistochemistry on a Diagnostic Biopsy by Warrier, S. K, Trainer, A. H, Lynch, A. C, Mitchell, C, Hiscock, R, Sawyer, S, Boussioutas, A, Heriot, A. G

“…BACKGROUND:DNA mismatch repair immunohistochemistry on tumor tissue is a simple, readily available, and cost-effective method of identifying patients with…”
Get full text

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer by Loughrey, M B, Waring, P M, Tan, A, Trivett, M, Kovalenko, S, Beshay, V, Young, M-A, McArthur, G, Boussioutas, A, Dobrovic, A

“…Patients suspected on clinical grounds to have hereditary non-polyposis colorectal cancer (HNPCC) may be offered laboratory testing in order to confirm the…”
Get full text

2200 TOPGEAR: A randomized phase M/MI trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer. Interim results from an international, intergroup trial of the AGITG/TROG/NCIC CTG/EORTC by Leong, T, Smithers, B.M, Michael, M, Gebski, V, Simes, J, Boussioutas, A, Miller, D, Zalcberg, J, O'Connell, R, Swallow, C, Darling, G, Wong, R, Schuhmacher, C, Lordick, F, Haustermans, K

Get full text

2079 Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study by Jayasekara, H, Reece, J, Dashti, S.G, Buchanan, D, Rosty, C, Macrae, F, Boussioutas, A, Giles, G, Ahnen, D, Lowery, J, Casey, G, Haile, R, Gallinger, S, Marchand, L. Le, Newcomb, P, Lindor, N, Hopper, J, Parry, S, Jenkins, M, Win, A

Get full text

Gastrointestinal: Tuberculosis of the sigmoid colon-a cautionary tale by Philpott, HL, Boussioutas, A, Kronborg, I, Zanatti, S, Dow, C

Get full text

Towards a molecular approach to gastric cancer management by Boussioutas, A., Taupin, D.

“…Gastric cancer is a leading cause of cancer death worldwide. Most patients with gastric cancer present with locally advanced and incurable disease, and overall…”
Get full text

DOP10 Persistent sonographic Inflammation as a predictor of clinical complications in patients with Crohn’s Disease by Vaughan, R, Tjandra, D, Patwardhan, A, Mingos, N, Gibson, R, Boussioutas, A, Christensen, B

“…Abstract Background Transmural healing has emerged as a new treatment target and can be assessed non-invasively with intestinal ultrasound (IUS). We…”
Get full text

Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study by Kadri, Sudarshan R, Lao-Sirieix, Pierre, O’Donovan, Maria, Debiram, Irene, Das, Madhumita, Blazeby, Jane M, Emery, Jon, Boussioutas, Alex, Morris, Helen, Walter, Fiona M, Pharoah, Paul, Hardwick, Richard H, Fitzgerald, Rebecca C

“…Objectives To determine the accuracy and acceptability to patients of non-endoscopic screening for Barrett’s oesophagus, using an ingestible oesophageal…”
Get full text

MAGEA family gene expression influences survival in intestinal gastric cancer by Pattison, S., Leong, T., Busuttil, R.A., Boussioutas, A.

Get full text

P-236 Screening practices of Australians at population and familial risk following the partial roll-out of the National Bowel Cancer Screening Program, 2009-2012 by Flander, L., Jenkins, M., Win Aung, K., Boussioutas, A., Hopper, J., Giles, G., Winship, I., Macrae, F., Ait Ouakrim, D.

Get full text

Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts by Purdom, E, Restall, C, Busuttil, R A, Schluter, H, Boussioutas, A, Thompson, E W, Anderson, R L, Speed, T P, Haviv, I

“…Gene expression profiling using microarrays and xenograft transplants of human cancer cell lines are both popular tools to investigate human cancer. However,…”
Get more information

Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-β signaling by Zhu, Hong-Jian, Ernst, Matthias, Jenkins, Brendan J, Grail, Dianne, Nheu, Thao, Najdovska, Meri, Wang, Bo, Waring, Paul, Inglese, Melissa, McLoughlin, Rachel M, Jones, Simon A, Topley, Nicholas, Baumann, Heinz, Judd, Louise M, Giraud, Andrew S, Boussioutas, Alex

“…The latent transcription factor Stat3 is activated by gp130, the common receptor for the interleukin (IL)-6 cytokine family and other growth factor and…”
Get full text

Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer by Boussioutas, Alex, Li, Hong, Liu, Jia, Waring, Paul, Lade, Stephen, Holloway, Andrew J, Taupin, Douglas, Gorringe, Kylie, Haviv, Izhak, Desmond, Paul V, Bowtell, David D L

“…Current epidemiological evidence supports a pathogenetic model of gastric cancer involving intermediate stages that include chronic gastritis and intestinal…”
Get full text

Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? by Win, Aung Ko, Hopper, John L, Buchanan, Daniel D, Young, Joanne P, Tenesa, Albert, Dowty, James G, Giles, Graham G, Goldblatt, Jack, Winship, Ingrid, Boussioutas, Alex, Young, Graeme P, Parry, Susan, Baron, John A, Duggan, David, Gallinger, Steven, Newcomb, Polly A, Haile, Robert W, Marchand, Loïc Le, Lindor, Noralane M, Jenkins, Mark A

“…Abstract Background Genome-wide association studies have identified at least 15 independent common genetic variants associated with colorectal cancer (CRC)…”
Get full text

Defective macrophage handling of E scherichia coli in C rohn's disease by Elliott, TR, Hudspith, BN, Rayment, NB, Prescott, NJ, Petrovska, L, Hermon‐Taylor, J, Brostoff, J, Boussioutas, A, Mathew, CG, Sanderson, JD

“…Abstract Background and Aim   E scherichia coli can be isolated from lamina propria macrophages in C rohn's disease ( CD ), and their intramacrophage…”
Get full text